4Pierson SH, Katz DI, Tarsy D. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil, 1996, 77(7): 717-721.
5Bhakta BB, Cozens JA, Bamford JM, et al. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry, 1996, 61(1): 30-35.
6Panizza M, Castagna M, di Suman A, et al. Functional and clinical changes in upper limb spastic patents treated with botulinum toxin (BTX). Funct Neurol, 2000, 15(3): 147 - 155.
7Hesse S, Krajnik J, Lueke D, et al. Ankle muscle activity before and after botulinum toxin therapy for lowers limb extensor spasticity in chronic hemiparetic patients. Stroke, 1996, 27(3): 455-460.
8Reiter F, Danni M, Lagalla G, et al. Low- dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil, 1998, 79(5): 532-535.
9Viriyavejakul A, Vachatathiti E, Pouguarin N. Botulinum treatment for post - stroke spasticity: low dose regime. J Med Assoc Thai, 1998, 81 (6): 413 - 422.
10Simpson DM, Alexander DN, O'Brien CF, et al. Batulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double -blind, placebo-controlled trial. Neurology, 1996, 46(5): 1306-1310.
